Literature DB >> 7143171

Age-related probability of development of hereditary medullary thyroid carcinoma.

R F Gagel, C E Jackson, M A Block, Z T Feldman, S Reichlin, B P Hamilton, A H Tashjian.   

Abstract

Hereditary medullary thyroid carcinoma is inherited as an autosomal dominant trait; at birth each child of an affected parent has a 50% chance of developing the disease. Measurement of plasma calcitonin concentrations after provocative calcium or pentagastrin stimulation has proved useful in the early diagnosis of this disease. To determine the age-related risk of conversion from a negative to a positive provocative test, 445 members of 11 kindreds were studied with sequential tests. Of 159 family members with a 50% risk at birth of developing medullary thyroid carcinoma 38 converted from a negative to a positive test result (mean age of conversion was 15 years). By means of methods previously described for determining the age-related probability for developing Huntington chorea, we present a method for determining the probability of development of medullary thyroid carcinoma. An individual at risk whose test result was negative had the following probability of converting to a positive test result at a later date: age (years)/probability, 0/0.5; 5/0.49; 10/0.41; 15/0.25; 20/0.16; 25/0.10, 30/0.05; and 35/0. We conclude that hereditary medullary thyroid carcinoma is regularly detectable in the pediatric age group and that screening should begin by age 5 years and be continued at regular intervals until age 35.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143171     DOI: 10.1016/s0022-3476(82)80014-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma.

Authors:  S A Narod; H Sobol; Y Nakamura; C Calmettes; J L Baulieu; J C Bigorgne; G Chabrier; J Couette; J L de Gennes; J Duprey
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

2.  Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression.

Authors:  L M McGregor; B K McCune; J R Graff; P R McDowell; K E Romans; G D Yancopoulos; D W Ball; S B Baylin; B D Nelkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  Screening for familial medullary thyroid carcinoma: a review.

Authors:  B A Ponder
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

4.  The clinical and screening age-at-onset distribution for the MEN-2 syndrome.

Authors:  D F Easton; M A Ponder; T Cummings; R F Gagel; H H Hansen; S Reichlin; A H Tashjian; M Telenius-Berg; B A Ponder
Journal:  Am J Hum Genet       Date:  1989-02       Impact factor: 11.025

5.  Linkage analysis of a DNA marker localized to 20p12 and multiple endocrine neoplasia type 2A.

Authors:  P J Goodfellow; B N White; J J Holden; A M Duncan; E V Sears; H S Wang; L Berlin; K K Kidd; N E Simpson
Journal:  Am J Hum Genet       Date:  1985-09       Impact factor: 11.025

6.  The clinical implications of a positive calcitonin test for C-cell hyperplasia in genetically unaffected members of an MEN2A kindred.

Authors:  R M Landsvater; A G Rombouts; G J te Meerman; J M Schillhorn-van Veen; M J Berends; R A Geerdink; A Struyvenberg; C H Buys; C J Lips
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

7.  An efficient strategy for gene mapping using multipoint linkage analysis: exclusion of the multiple endocrine neoplasia 2A (MEN2A) locus from chromosome 13.

Authors:  L A Farrer; P J Goodfellow; C M Lamarche; I Franjkovic; S Myers; B N White; J J Holden; J R Kidd; N E Simpson; K K Kidd
Journal:  Am J Hum Genet       Date:  1987-04       Impact factor: 11.025

8.  High resolution chromosome and DNA analysis in multiple endocrine neoplasia type II syndrome.

Authors:  M G Butler; D R Repaske; G M Joseph; J A Phillips
Journal:  Cancer Genet Cytogenet       Date:  1987-01

9.  The genetic defect in multiple endocrine neoplasia type 2A maps next to the centromere of chromosome 10.

Authors:  J S Wu; N L Carson; S Myers; A J Pakstis; J R Kidd; C M Castiglione; L Anderson; L S Hoyle; M Genel; M Verdy
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

Review 10.  Is calcitonin an important physiological substance?

Authors:  Philip F Hirsch; Hans Baruch
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.